24 May 2013
Keywords: ropinirole, relieves, parkinson, symptoms, clinical, studies, smithkline
Article | 08 April 1996
Three clinical studies of SmithKline Beecham's dopamine D2 receptor agonist Requip (ropinirole) have reinforced the value of using the drug ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.